pharma · Colorectal Cancer Screening · Screening for Colon Cancer · MRKR
ME Therapeutics
Marker Therapeutics
ME Therapeutics is a pharma organization headquartered in Vancouver, CA. It trades on NYSE under ticker MRKR. Primary therapeutic focus areas include Colorectal Cancer Screening, Screening for Colon Cancer, Platinum Sens
Vancouver, British Columbia, CA HQ
2018 Founded
4 Employees
Public company Type
MRKR · NYSE Ticker
Company details
- Status
- Public
- HQ
- Vancouver, British Columbia, CA
- Founded
- 2018
- Employees
- 4
- Programs
- 13
- Drugs
- 10
- Patents
- 27
blood sampling
Unknown · other · Colorectal Cancer Screening
blood sampling for Colorectal Cancer Screening is a Unknown program (other) at Marker Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code AMD-EUC-2016
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Marker Therapeutics
- Phase
- Unknown
- Modality
- other
- Indication
- Colorectal Cancer Screening
- Status
- completed
- Trials
- 1